146
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Associations of Two Novel Inflammation Biomarkers, SIRI and SII, with Mortality Risk in Patients with Chronic Heart Failure

, , , , , , , ORCID Icon, , & show all
Pages 1255-1264 | Received 22 Nov 2023, Accepted 16 Feb 2024, Published online: 23 Feb 2024

References

  • Heidenreich PA, Bozkurt B, Aguilar D, et al. AHA/ACC/HFSA guideline for the management of heart failure: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2022;145(18):e895–e1032. doi:10.1161/CIR.0000000000001063
  • Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123–1133. doi:10.1016/j.jacc.2013.11.053
  • Hao G, Wang X, Chen Z, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015. Eur J Heart Fail. 2019;21(11):1329–1337. doi:10.1002/ejhf.1629
  • Keşkek Ş, Sağlıker Y, Kırım S, Içen YK, Yıldırım A. Low serum phosphorus level in Massry’s Phosphate Depletion Syndrome may be one of the causes of acute heart failure. J Nutr Sci Vitaminol. 2015;61(6):460–464. doi:10.3177/jnsv.61.460
  • Kaptoge S, Di Angelantonio E, Pennells L, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367(14):1310–1320.
  • Kaplan RC, Frishman WH. Systemic inflammation as a cardiovascular disease risk factor and as a potential target for drug therapy. Heart Dis. 2001;3(5):326–332. doi:10.1097/00132580-200109000-00009
  • Tian SY. Systemic immune-inflammation index predicts restenosis after interventions for lower extremity arteriosclerosis obliterans. Heart Surg Forum. 2023;26(3):E225–E233. doi:10.1532/hsf.5303
  • Lin K, Lan Y, Wang A, Yan Y, Ge J. The association between a novel inflammatory biomarker, systemic inflammatory response index and the risk of diabetic cardiovascular complications. Nutr Metab Cardiovasc Dis. 2023;33(7):1389–1397. doi:10.1016/j.numecd.2023.03.013
  • Aksakal E, Aksu U, Birdal O, et al. Role of systemic immune-inflammatory index in predicting the development of in-hospital malignant ventricular arrhythmia in patients with ST-elevated myocardial infarction. Angiology. 2023;74(9):881–888. doi:10.1177/00033197221121435
  • Jin Z, Wu Q, Chen S, et al. The associations of two novel inflammation indexes, SII and SIRI with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85,154 individuals. J Inflamm Res. 2021;14:131–140. doi:10.2147/JIR.S283835
  • Li J, He D, Yu J, et al. Dynamic status of SII and SIRI alters the risk of cardiovascular diseases: evidence from Kailuan cohort study. J Inflamm Res. 2022;15:5945–5957. doi:10.2147/JIR.S378309
  • Esenboga K, Kurtul A, Yamanturk YY, Tan TS, Tutar DE. Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention. Acta Cardiol. 2022;77(1):59–65. doi:10.1080/00015385.2021.1884786
  • Cao Y, Li P, Zhang Y, et al. Association of systemic immune inflammatory index with all-cause and cause-specific mortality in hypertensive individuals: results from NHANES. Front Immunol. 2023;14:1087345. doi:10.3389/fimmu.2023.1087345
  • Xiao S, Wang Z, Zuo R, et al. Association of systemic immune inflammation index with all-cause, cardiovascular disease, and cancer-related mortality in patients with cardiovascular disease: a cross-sectional study. J Inflamm Res. 2023;16:941–961. doi:10.2147/JIR.S402227
  • McDonagh TA, Metra M, Adamo M, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
  • Wang X, Ni Q, Wang J, Wu S, Chen P, Xing D. Systemic inflammation response index is a promising prognostic marker in elderly patients with heart failure: a retrospective cohort study. Front Cardiovasc Med. 2022;9:871031. doi:10.3389/fcvm.2022.871031
  • Yuan M, Ren F, Gao D. The value of SII in predicting the mortality of patients with heart failure. Dis Markers. 2022;2022:3455372. doi:10.1155/2022/3455372
  • Tang Y, Zeng X, Feng Y, et al. Association of systemic immune-inflammation index with short-term mortality of congestive heart failure: a retrospective cohort study. Front Cardiovasc Med. 2021;8:753133. doi:10.3389/fcvm.2021.753133
  • Wang Z, Qin Z, Yuan R, et al. Systemic immune-inflammation index as a prognostic marker for advanced chronic heart failure with renal dysfunction. ESC Heart Fail. 2023;10(1):478–491. doi:10.1002/ehf2.14217
  • Dick SA, Epelman S. Chronic heart failure and inflammation: what do we really know? Circ Res. 2016;119(1):159–176. doi:10.1161/CIRCRESAHA.116.308030
  • Van Linthout S, Tschope C. Inflammation - cause or consequence of heart failure or both? Curr Heart Fail Rep. 2017;14(4):251–265. doi:10.1007/s11897-017-0337-9
  • Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2020;17(5):269–285. doi:10.1038/s41569-019-0315-x
  • Kan H, Finkel MS. Interactions between cytokines and neurohormonal systems in the failing heart. Heart Fail Rev. 2001;6(2):119–127. doi:10.1023/A:1011405926588
  • Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23(34):6261–6272. doi:10.3748/wjg.v23.i34.6261
  • Fu H, Zheng J, Cai J, et al. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients after liver transplantation for hepatocellular carcinoma within Hangzhou criteria. Cell Physiol Biochem. 2018;47(1):293–301. doi:10.1159/000489807
  • Geng Y, Zhu D, Wu C, et al. A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. Int Immunopharmacol. 2018;65:503–510. doi:10.1016/j.intimp.2018.10.002
  • Liu X, Zhou K, Hua Y, et al. Prospective evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients. Pediatr Infect Dis J. 2020;39(3):229–231. doi:10.1097/INF.0000000000002566
  • Majmundar M, Kansara T, Park H, et al. Absolute lymphocyte count as a predictor of mortality and readmission in heart failure hospitalization. Int J Cardiol Heart Vasc. 2022;39:100981.
  • Fu S, Xie L, Li D, Ye P, Luo L. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure. Clin Interv Aging. 2015;10:359–365. doi:10.2147/CIA.S77417
  • Li Q, Lin X, Bo X, et al. Monocyte to high-density lipoprotein cholesterol ratio predicts poor outcomes in ischaemic heart failure patients combined with diabetes: a retrospective study. Eur J Med Res. 2023;28(1):493. doi:10.1186/s40001-023-01451-6
  • Chen Q, Yin Q, Song J, Liu C, Chen H, Li S. Identification of monocyte-associated genes as predictive biomarkers of heart failure after acute myocardial infarction. BMC Med Genomics. 2021;14(1):44. doi:10.1186/s12920-021-00890-6
  • Hwang SY, Shin TG, Jo IJ, et al. Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients. Am J Emerg Med. 2017;35(2):234–239. doi:10.1016/j.ajem.2016.10.055
  • Chung I, Choudhury A, Patel J, Lip GY. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure. Ann Med. 2009;41(1):45–51. doi:10.1080/07853890802227089